Denmark's Novo Nordisk and South Africa's Aspen sign a deal to produce insulin for African patients
Published
CAPE TOWN, South Africa (AP) — Danish pharmaceutical company Novo Nordisk signed a deal with South Africa's Aspen Pharmacare to produce human insulin for diabetes patients in Africa, where there is a dire need for the life-saving treatment. The Africa Centers for Disease Control and Prevention…
#southafrica #danish #novonordisk #pharmacare #africa #gqeberha #african